A 2026 study found a 53% lower adjusted risk of long COVID or death with early metformin prescriptions. Researchers explain the evidence and limitations.
Metformin Linked to 53% Lower Long COVID Risk in New Study
A 2026 study found a 53% lower adjusted risk of long COVID or death with early metformin prescriptions. Researchers explain the evidence and limitations.